STRM vs. IDN, LGCL, PODC, RAAS, SST, MTBLY, AIFF, WAVS, AOGO, and MNDO
Should you be buying Streamline Health Solutions stock or one of its competitors? The main competitors of Streamline Health Solutions include Intellicheck (IDN), Lucas GC (LGCL), PodcastOne (PODC), Cloopen Group (RAAS), System1 (SST), Moatable (MTBLY), Firefly Neuroscience (AIFF), Western Acquisition Ventures (WAVS), Arogo Capital Acquisition (AOGO), and MIND C.T.I. (MNDO). These companies are all part of the "computer software" industry.
Streamline Health Solutions vs.
Streamline Health Solutions (NASDAQ:STRM) and Intellicheck (NYSE:IDN) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation, community ranking and profitability.
Streamline Health Solutions received 195 more outperform votes than Intellicheck when rated by MarketBeat users. However, 50.00% of users gave Intellicheck an outperform vote while only 47.27% of users gave Streamline Health Solutions an outperform vote.
Intellicheck has higher revenue and earnings than Streamline Health Solutions. Intellicheck is trading at a lower price-to-earnings ratio than Streamline Health Solutions, indicating that it is currently the more affordable of the two stocks.
Streamline Health Solutions has a beta of 1.77, meaning that its stock price is 77% more volatile than the S&P 500. Comparatively, Intellicheck has a beta of 1.9, meaning that its stock price is 90% more volatile than the S&P 500.
In the previous week, Intellicheck had 15 more articles in the media than Streamline Health Solutions. MarketBeat recorded 16 mentions for Intellicheck and 1 mentions for Streamline Health Solutions. Streamline Health Solutions' average media sentiment score of 1.90 beat Intellicheck's score of 0.73 indicating that Streamline Health Solutions is being referred to more favorably in the media.
31.7% of Streamline Health Solutions shares are held by institutional investors. Comparatively, 42.8% of Intellicheck shares are held by institutional investors. 30.6% of Streamline Health Solutions shares are held by insiders. Comparatively, 8.9% of Intellicheck shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Intellicheck has a net margin of -3.37% compared to Streamline Health Solutions' net margin of -50.51%. Intellicheck's return on equity of -1.59% beat Streamline Health Solutions' return on equity.
Intellicheck has a consensus target price of $3.33, indicating a potential upside of 28.70%. Given Intellicheck's higher probable upside, analysts clearly believe Intellicheck is more favorable than Streamline Health Solutions.
Summary
Intellicheck beats Streamline Health Solutions on 13 of the 19 factors compared between the two stocks.
Get Streamline Health Solutions News Delivered to You Automatically
Sign up to receive the latest news and ratings for STRM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Streamline Health Solutions Competitors List
Related Companies and Tools
This page (NASDAQ:STRM) was last updated on 3/28/2025 by MarketBeat.com Staff
